Joe Lawson
Janssen (Belgium)(BE)Janssen (United States)(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Cancer, Lipids, and Metabolism, Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial(2018)128 cited
- → Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden(2020)62 cited
- → Introducing PIONEER: a project to harness big data in prostate cancer research(2020)39 cited
- → Relationship Between Metastasis-free Survival and Overall Survival in Patients With Nonmetastatic Castration-resistant Prostate Cancer(2019)21 cited
- → Understanding symptomatic experience, impact, and emotional response in recently diagnosed metastatic castration-resistant prostate cancer: a qualitative study(2019)16 cited
- → Association of metastasis-free survival (MFS) and overall survival (OS) in nonmetastatic castration-resistant prostate cancer (nmCRPC).(2018)9 cited
- → Time-to-event Outcomes in Men with Nonmetastatic Castrate-resistant Prostate Cancer—A Systematic Literature Review and Pooling of Individual Participant Data(2018)8 cited
- → Correlation between FGFR mutation and PD-L1 expression of urinary bladder cancers: A real-world based biomarker study.(2019)7 cited
- → PD10-04 A POPULATION-BASED STUDY OF THE ASSOCIATION OF PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME (PSADT) WITH METASTASIS-FREE SURVIVAL (MFS) AND OVERALL SURVIVAL (OS) IN NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) PATIENTS (PTS)(2018)6 cited
- → Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research(2020)5 cited